Liquid Biopsy Market: Is 2026 the Year "Epigenetic...

added blog Health

2026-03-05 11:19:05 -

Liquid Biopsy Market: Is 2026 the Year "Epigenetic Mapping" Becomes the Final Word in Early Cancer Screening

The Liquid Biopsy Market in 2026 has officially entered its "High-Growth Era," with a projected CAGR of 28.61% through the end of the decade. The star of the 2026 show is "Epigenetic Profiling," a technology that looks at the "chemical tags" on DNA rather than the mutations themselves. In 2026, this has enabled the development of "Pan-Cancer" tests that can detect the specific organ of origin...

0 Comments 0 Shares 92 Views 0 Reviews